PELP1 and breast carcinoma: Although assessment of strong PELP1 expression in the TNBC group is not available from the Habashy et al. study, the positive correlation of PELP1 with expression of basal cytokeratin (CK-14, CK-5/6) and the negative correlation with ER and PR in unselected breast cancer reported in that study suggested a relatively higher expression of PELP1 in TNBC [14].